1.80
1.80 (0%)
As of Apr 25, 2025
Cronos Group Inc. [CRON]
Source:
Company Overview
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development.
| Country | United States |
| Headquarters | toronto, ontario |
| Phone Number | 416 - 504-0004 |
| Industry | manufacturing |
| CEO | Michael Gorenstein |
| Website | thecronosgroup.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $117.6 |
| Operating Profit | $-76.5 |
| Net Income | $40 |
| Net Cash | $189.5 |
Profit Ratios
| Gross Margin | $25.2 |
| Operating Margin | -65.1 |
| Profit as % of Revenues | 63% |
| Profit as % of Assets | 3.5% |
| Profit as % of Stockholder Equity | 3.6% |
Management Effectiveness
| Return on Equity | 3.6% |
| Return on Assets | 3.4% |
| Turnover Ratio | 10.2% |
| EBITA | $-72.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,166.3 |
| Total Liabilities | $55.3 |
| Operating Cash Flow | $18.8 |
| Investing Cash Flow | $175.1 |
| Financing Cash Flow | $-1.2 |
